4
Dec 2025
For the first time, researchers have observed live and in high resolution how influenza viruses infect living cells. This was possible thanks to a new microscopy technique, which could now help to develop antiviral therapies in a more targeted manner.
4
Dec 2025
Long-term exposure to common air pollutants is associated with more advanced coronary artery disease-with notable differences between women and men-according to a large-scale study of more than 11,000 adults being presented today at the annual meeting of the Radiological Society of North America (RSNA).
4
Dec 2025
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required.
4
Dec 2025
Magnetic resonance imaging (MRI) is invaluable in the medical world. But despite all the good it does, there is room for improvement.
4
Dec 2025
Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that reinforce repeated use and make quitting extremely difficult.
4
Dec 2025
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.
4
Dec 2025
In newly published research, Binghamton University doctoral student Elana Israel, MS '22, explores which depressive symptoms largely affect children's neural responses to feedback.
4
Dec 2025
A new study examined CRAFT-G, a remote group intervention combining cognitive training, psychoeducation, and occupational-therapy-based strategies for adults experiencing cancer-related cognitive impairment.
4
Dec 2025
Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.
4
Dec 2025
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
